January 26, 2023
UC San Diego and its collaborating partners have been awarded $10 million from the Howard Hughes Medical Institute to leverage the biomedical promise of viruses known as bacteriophages as new therapeutic agents in the fight against the rising crisis of antibiotic-resistant bacterial infections.
October 16, 2024
UC San Diego School of Medicine researchers discover a groundbreaking oral breast cancer drug that is also effective in treating a rare form of appendix cancer.
January 24, 2022
A joint gift to the University of Southern California (USC) and the University of California San Diego totaling $50 million from the Epstein Family Foundation will drive Alzheimer’s research and accelerate the search for treatments and a cure.
October 2, 2024
…“gateway into the nucleus” could open new possibilities in gene therapy, where genetic material needs to be delivered directly into the nucleus, as well as drug delivery and other forms of precision medicine.
July 3, 2012
Research suggests that patients with leukemia sometimes relapse because standard chemotherapy fails to kill the self-renewing leukemia initiating cells, often referred to as cancer stem cells. In such cancers, the cells lie dormant for a time, only to later begin cloning, resulting in a return and metastasis of the disease.…
July 29, 2015
A new study by researchers at University of California, San Diego School of Medicine reveals a protein’s critical – and previously unknown – role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer. The finding offers a novel target for better treating…
May 25, 2014
Researchers at the University of California, San Diego School of Medicine have identified a mutated gene common to adenosquamous carcinoma (ASC) tumors – the first known unique molecular signature for this rare, but particularly virulent, form of pancreatic cancer.
December 20, 2023
In a groundbreaking development in the field of anti-acne therapies, a team of researchers has created an acne vaccine that, when used in a mouse acne model, neutralizes a specific variant of an enzyme produced by an acne-associated bacteria while leaving the healthy bacterial enzyme intact.
June 17, 2015
…over a lifetime despite the fact that most organisms generate few new heart cells. Identifying key gene expression changes that promote heart function as organisms age could lead to new therapy targets that address age-related heart failure.
August 4, 2016
…a new type of immunotherapy, known as CAR T-cell therapy, as part of a Phase I/II clinical trial at Moores Cancer Center at UC San Diego Health.
